{"retracted":false,"update":{"timestamp":1435708800000,"doi":"10.1016/j.thromres.2015.03.024","type":"erratum"},"doi":"10.1016/j.thromres.2014.06.032","journal":"Thrombosis Research","publisher":"Elsevier BV","title":"Corrigendum to ‘Rivaroxaban for the treatment of venous thromboembolism. A “real-life” perspective in 103 patients’ [Thrombosis Research 134 (2014) 617–621]"}
